Sep 01, 09:09
Sep 01, 09:07
AnnouncementsDishman Pharmaceuticals: Outcome of board meeting
52% of moneycontrol users recommend buying Dishman Pharma.
What's your call on Dishman Pharma today?
Read 6 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2963.05||0.40||2969.00||2286.80||50,471.12|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 320.85 81.27%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Dishman Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,255.65 crore.The company has reported a consolidated sales of Rs 361.56 crore and a Net Profit of Rs 23.78 crore for the quarter ended Jun 2014.
The company management includes Janmejay R Vyas - Chairman & Managing Director, Arpit J Vyas - Managing Director, Yagneshkumar B Desai - Director, Sanjay S Majmudar - Director, Ashok C Gandhi - Director, Deohooti J Vyas - Whole Time Director.
It is listed on the BSE with a BSE Code of 532526 and the NSE with an NSE Code of DISHMAN.
Its Registered office is at Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura. Ahmedabad,Gujarat - 380009.
Their Registrars are Link Intime India Pvt. Ltd.